Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Eureka 93 Inc LXLLF

Eureka 93 Inc is a Canada based company involved in hemp cultivation and CBD extraction operations in North America. The product offerings of the company include Wholesale CBD Products, Full Plant Extract and Isolate Powder.

GREY:LXLLF - Post Discussion

Eureka 93 Inc > Livewell have no control over the ticker on the OTC
View:
Post by Bullsnbulls on Jan 08, 2019 1:58pm

Livewell have no control over the ticker on the OTC

Investor relations rponse : Thank you for your email, The OTC is a gray market, that is , it is not a regulated and a liquid market. We have no control over the OTC However we have requested to be rated on the otc .QB which is regulated by FINRA. Once approved , we will be stopped until we resume our trading on the cse. We intend to transfer our listing to the NASDAQ in the coming months. Thank you
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities